{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T18:33:52Z","timestamp":1648665232057},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"published-print":{"date-parts":[[1994,7]]},"DOI":"10.2165\/00019053-199406010-00007","type":"journal-article","created":{"date-parts":[[2007,12,5]],"date-time":"2007-12-05T11:26:51Z","timestamp":1196854011000},"page":"57-89","source":"Crossref","is-referenced-by-count":3,"title":["Ranitidine"],"prefix":"10.1007","volume":"6","author":[{"given":"James E.","family":"Frampton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"McTavish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","container-title":["PharmacoEconomics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2013,1,20]],"date-time":"2013-01-20T14:36:25Z","timestamp":1358692585000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/00019053-199406010-00007"}},"subtitle":["A Pharmacoeconomic Evaluation of its Use in Acid-Related Disorders"],"short-title":[],"issued":{"date-parts":[[1994,7]]},"references-count":0,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.2165\/00019053-199406010-00007","relation":{},"ISSN":["1170-7690"],"issn-type":[{"value":"1170-7690","type":"print"}],"subject":[],"published":{"date-parts":[[1994,7]]}}}